{
  "ticker": "CMP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976469",
  "id": "02976469",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250804",
  "time": "0945",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250804/pdf/06mhl7jrfdwn20.pdf",
  "summary": "### Summary of Material Information:  \n- **New Sales Contracts**: Somfit sales secured with a major US CRO and Orion Pharma (Europe), totaling ~$2M revenue.  \n- **Market Expansion**: Validates entry into pharmaceutical clinical trial sector beyond core sleep testing market.  \n- **Strategic Significance**: Demonstrates Somfit's competitive edge in EEG-based sleep monitoring for drug trials.  \n\n*No capital markets actions (e.g., raising, halt) or financial metrics (e.g., cash balance) disclosed.*",
  "usage": {
    "prompt_tokens": 1009,
    "completion_tokens": 105,
    "total_tokens": 1114,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-03T23:55:51.229100"
}